Lauren Dembeck, PhD

Researchers sought to determine whether postoperative radiotherapy would be safe and effective for patients who receive spinal surgery osteolytic lesions of multiple myeloma.

Researchers sought to determine whether MRD status would be predictive of outcomes after induction and during maintenance in previously untreated patients with FL.

Researchers sought to determine whether midostaurin in combination with intensive chemotherapy would be effective in adult patients with FLT3-mutated AML.

Researchers sought to determine the prevalence of reduced function among survivors of ALL and NHL by treatment decade.

Researchers sought to determine whether a chemo-free combination of rituximab and lenalidomide in frontline therapy would be effective in older patients with DLBCL.

Researchers sought to determine the use of PET-CT scans and Deauville scores for patients with stage III/IV cHL undergoing frontline therapy in a community oncology setting.

Researchers sought to determine whether the CAR‑HEMATOTOX score would have prognostic value for both toxicity and treatment response in patients with R/R MM receiving CAR-T therapy.

Researchers sought to determine whether homoharringtonine-based induction therapy would lower disease recurrence in pediatric patients with AML after HSCT.

Researchers sought to determine whether nivolumab would improve PFS compared with brentuximab vedotin in patients with advanced-stage cHL.

Researchers sought to determine whether axi-cel would have efficacy and safety for treating follicular lymphoma in a real-world setting compared with the ZUMA-5 trial.